Factors such as temperature, oxygen, and glucose have recently been implicated in the development of surgical sepsis by either promoting or attenuating protective components of the innate immune response. Reducing infective sequelae and the improvement of the quality of care of surgical patients is a top practice priority today. These factors and their associated effects are discussed through the examination of recent clinical and scientific studies to provide an up-to-date evidence-based review.
Get full access to this article
View all access options for this article.
References
1.
MilesA.A., MilesE.M., BurkeJ.The value and duration of defence reactions of the skin to the primary lodgement of bacteria.Br J Exp Pathol1957; 38: 79–96.
2.
HopfH.W., HuntT.K., WestJ.M.Wound tissue oxygen tension predicts the risk of wound infection in surgical patients.Arch Surg1997; 132: 997–1004.
3.
KlugerM.J.Fever—its biology, evolution and function.Princeton, NJ: Princeton University Press; 1979.
4.
HasdayJ.D., GarrisonA.Antipyretic therapy in patients with sepsis.Clin Infect Dis2000; 31(suppl 5): S234–41.
5.
OstbergJ.R., RepaskyE.A.Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations.Int J Hyperthermia2000; 16: 29–43.
6.
KimuraA., SakuradaS., OhkuniH.Moderate hypothermia delays proinflammatory cytokine production of human peripheral blood mononuclear cells.Crit Care Med2002; 30: 1499–502.
7.
EnsorJ.E., WienerS.M., McCreaK.A.Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-alpha expression.Am J Physiol1994; 266: C967–74.
8.
JiangQ., CrossA.S., SinghI.S.Febrile core temperature is essential for optimal host defense in bacterial peritonitis.Infect Immun2000; 68: 1265–70.
9.
FairchildK.D., ViscardiR.M., HesterL.Effects of hypothermia and hyperthermia on cytokine production by cultured human mononuclear phagocytes from adults and newborns.J Interferon Cytokine Res2000; 20: 1049–55.
10.
KurzA., SesslerD.I., LenhardtR.Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group.N Engl J Med1996; 334: 1209–15.
11.
FrankS.M., FleisherL.A., BreslowM.J.Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial.JAMA1997; 277: 1127–34.
12.
LunaG.K., MaierR.V., PavlinE.G.Incidence and effect of hypothermia in seriously injured patients.J Trauma1987; 27: 1014–8.
13.
SchmiedH., KurzA., SesslerD.I.Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty.Lancet1996; 347: 289–92.
CarliF., EmeryP.W., FreemantleC.A.Effect of perioperative normothermia on postoperative protein metabolism in elderly patients undergoing hip arthroplasty.Br J Anaesth1989; 63: 276–82.
16.
KurzA., PlattnerO., SesslerD.I.The threshold for thermoregulatory vasoconstriction during nitrous oxide/isoflurane anesthesia is lower in elderly than in young patients.Anesthesiology1993; 79: 465–9.
17.
PengR.Y., BongardF.S.Hypothermia in trauma patients.J Am Coll Surg1999; 188: 685–96.
18.
KlugerM.J., KozakW., ConnC.A.The adaptive value of fever.Infect Dis Clin North Am1996; 10: 1–20.
19.
KurzA.Physiology of thermoregulation.Best Pract Res Clin Anaesthesiol2008; 22: 627–44.
20.
GalandiukS., MahidS.S., PolkH.C.Jr.. Differences and similarities between rural and urban operations.Surgery2006; 140: 589–96.
GreifR., AkcaO., HornE.P.Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group.N Engl J Med2000; 342: 161–7.
23.
LeijhP.C., van den BarselaarM.T., van ZwetT.L., Dubbeldeman-RemptI.van FR. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes.Immunology1979; 37: 453–65.
24.
van OssC.J., AbsolomD.R., MooreL.L.Effect of temperature on the chemotaxis, phagocytic engulfment, digestion and O2 consumption of human polymorphonuclear leukocytes.J Reticuloendothel Soc1980; 27: 561–5.
25.
WenischC., NarztE., SesslerD.I.Mild intraoperative hypothermia reduces production of reactive oxygen intermediates by polymorphonuclear leukocytes.Anesth Analg1996; 82: 810–6.
26.
DitschkowskiM., KreuzfelderE., RebmannV.HLA-DR expression and soluble HLA-DR levels in septic patients after trauma.Ann Surg1999; 229: 246–54.
27.
LivingstonD.H., AppelS.H., WellhausenS.R.Depressed interferon gamma production and monocyte HLA-DR expression after severe injury.Arch Surg1988; 123: 1309–12.
28.
PolkH.C.Jr., TrachtenbergL., GeorgeC.D.A randomized, double-blind trial of single dose piperacillin versus multidose cefoxitin in alimentary tract operations.Am J Surg1986; 152: 517–21.
29.
CheadleW.G., WilsonM., HershmanM.J.Comparison of trauma assessment scores and their use in prediction of infection and death.Ann Surg1989; 209: 541–5.
30.
HershmanM.J., CheadleW.G., WellhausenS.R.Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient.Br J Surg1990; 77: 204–7.
31.
QadanM., GardnerS.A., VitaleD.S.Hypothermia and surgery: Immunologic mechanisms for current practice.Ann Surg2009 Jul; 250(1): 134–40.
32.
BeutlerB., MilsarkI.W., CeramiA.C.Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.Science1985; 229: 869–71.
33.
Van der PollT., KeoghC.V., BuurmanW.A., LowryS.F.Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice.Am J Respir Crit Care Med1997; 155: 603–8.
34.
Van der PollT.Immunotherapy of sepsis.Lancet Infect Dis2001; 1: 165–74.
LekkouA., KarakantzaM., MouzakiA.Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections.Clin Diagn Lab Immunol2004; 11: 161–7.
37.
QadanM., AkcaO., MahidS.S.Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials.Arch Surg2009; 144: 359–66.
38.
MylesP.S., LeslieK., ChanM.T.Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial.Anesthesiology2007; 107: 221–31.
39.
FleischmannE., LenhardtR., KurzA.Nitrous oxide and risk of surgical wound infection: a randomised trial.Lancet2005; 366: 1101–7.
40.
PryorK.O., FaheyT.J.III, LienC.A., GoldsteinP.A.Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial.JAMA2004; 291: 79–87.
41.
DellingerE.P.Increasing inspired oxygen to decrease surgical site infection: time to shift the quality improvement research paradigm.JAMA2005; 294: 2091–2.
42.
JonssonK., JensenJ.A., GoodsonW.H.III. Assessment of perfusion in postoperative patients using tissue oxygen measurements.Br J Surg1987; 74: 263–7.
43.
HartmannM., JonssonK., ZederfeldtB.Effect of tissue perfusion and oxygenation on accumulation of collagen in healing wounds. Randomized study in patients after major abdominal operations.Eur J Surg1992; 158: 521–6.
44.
BasslerD., Ferreira-GonzalezI., BrielM.Systematic reviewers neglect bias that results from trials stopped early for benefit.J Clin Epidemiol2007; 60: 869–73.
45.
BeldaF.J., AguileraL., GarciadlA. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial.JAMA2005; 294: 2035–42.
46.
GendallK.A., RanigaS., KennedyR., FrizelleF.A.The impact of obesity on outcome after major colorectal surgery.Dis Colon Rectum2007; 50: 2223–37.
GardellaC., GoltraL.B., LaschanskyE.High-concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial.Obstet Gynecol2008; 112: 545–52.
49.
MaragakisL.L., CosgroveS.E., MartinezE.A.Intra-operative fraction of inspired oxygen is a modifiable risk factor for surgical site infection after spinal surgery.Anesthesiology2009; 110: 556–62.
50.
Van den BergheG., WoutersP., WeekersF.Intensive insulin therapy in the critically ill patients.N Engl J Med2001; 345: 1359–67.
51.
BochicchioG.V., SungJ., JoshiM.Persistent hyperglycemia is predictive of outcome in critically ill trauma patients.J Trauma2005; 58: 921–4.
52.
LairdA.M., MillerP.R., KilgoP.D.Relationship of early hyperglycemia to mortality in trauma patients.J Trauma2004; 56: 1058–62.
53.
MalmbergK., RydenL., EfendicS.Randomized trial of insulin–glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.J Am Coll Cardiol1995; 26: 57–65.
54.
YendamuriS., FuldaG.J., TinkoffG.H.Admission hyperglycemia as a prognostic indicator in trauma.J Trauma2003; 55: 33–8.
55.
DoenstT., WijeysunderaD., KarkoutiK.Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery.J Thorac Cardiovasc Surg2005; 130: 1144.
56.
EstradaC.A., YoungJ.A., NifongL.W., ChitwoodW.R.Jr., Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting.Ann Thorac Surg2003; 75: 1392–9.
57.
GandhiG.Y., NuttallG.A., AbelM.D.Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients.Mayo Clin Proc2005; 80: 862–6.
58.
LathamR., LancasterA.D., CovingtonJ.F.The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients.Infect Control Hosp Epidemiol2001; 22: 607–12.
59.
TurinaM., MillerF.N., TuckerC.F., PolkH.C.Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms.Ann Surg2006; 243: 845–51.
60.
WienerR.S., WienerD.C., LarsonR.J.Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.JAMA2008; 300: 933–44.
61.
FinferS., ChittockD.R., SuS.Y.Intensive versus conventional glucose control in critically ill patients.N Engl J Med2009; 360: 1283–97.
62.
QadanM., BattistaC., GardnerS.A.Oxygen and surgical site infection: A study of underlying immunologic mechanisms.Anesthesiology. In press.
